Join 46,000+ subscribers getting smarter about psychedelics in under 10 minutes a week. Research 🔬, policy 🏛️, and business 📈, with a side of spicy memes. 🫠
I consent to receive newsletters via email. Sign Up Terms of Service.
Tap into our mycelial network.
[5-min read] Oxford study identifies patient types who benefit from psilocybin therapy.
[5-min read] Q&A with Joël Brierre, Founder & CEO
[4-min read] Congress sets a deadline for the VA's MDMA implementation plan.
[5-min read] Q&A with Reggie Harris, Founder & Educator
[5-min read] Church secures its legal right to serve ayahuasca.
[5-min read] Psychedelic practitioners face challenges with informed consent.
[5-min read] Q&A with Tricia Eastman, Medicine Woman & Author
[4-min read] New study suggests older adults respond in unique ways to psychedelics.
[5-min read] Q&A with Gabe Charalambides, Rocket Scientist & Founder
[5-min read] Beckley Psytech shares results from 5-MeO-DMT trial.